Diets containing either freeze-dried black raspberries (BRB) or their polyphenolic anthocyanins (AC) have been shown to inhibit the development of Nnitrosomethylbenzylamine (NMBA)-induced esophageal cancer in rats. The present study was conducted to determine if PCA, a major microbial metabolite of BRB AC, also prevents NMBA-induced esophageal cancer in rats. F344 rats were injected with NMBA three times a week (wk) for five weeks (wks) and then fed control or experimental diets containing 6.1% BRB, an AC-rich fraction derived from BRB, or PCA.
INTRODUCTION
Esophageal cancer is the third most common gastrointestinal cancer and sixth most common cancer worldwide. There are two types of esophageal cancer, squamous cell carcinoma (SCC) and adenocarcinoma, and SCC accounts for 90% of the disease worldwide (1, 2). The incidence of esophageal SCC is highly variable throughout the world with more than one-half of all cases occurring in China. The occurrence of the disease in males exceeds that in females by a factor of 3-to-4. Risk factors associated with the etiology of esophageal SCC include tobacco and alcohol use, consumption of foods contaminated with mold, vitamin and mineral deficiencies, temperature hot beverages and food, inadequate intake of vegetables and fruit, and infection with human papilloma virus (HPV) (3) (4) (5) (6) (7) (8) . Nitrosamine carcinogens and N-nitroso precursors present in foodstuffs and produced in the acidic environment of the stomach are also thought to contribute to the disease (9) . Esophageal SCC likely develops through a progressive sequence from hyperplasia >mild, moderate and severe dysplasia> carcinoma in situ> SCC. Because esophageal cancers are generally detected in the late stages of development, the five-year survival rate for SCC remains a dismal 15-20% (10) .
Life style changes such as avoidance of tobacco, alcohol and moldy foods are likely to be effective in reducing the incidence of esophageal SCC. Chemoprevention also has potential for reducing the risk for development of the disease. Support for this comes from epidemiological studies which have observed protective effects of naturallyoccurring fruits and vegetables on the risk for esophageal SCC (11, 12) . In that regard, The use of black raspberries (BRB) as a chemoprevention agent has gained interest and 6 human trials have been completed to date to assess the efficacy of BRB formulations for cancer prevention (17) . High concentrations of chemopreventive compounds such as the anthocyanins, ellagic acid, quercetin, and β-sitosterol have been identified in BRB (14, 18) . BRB and their component anthocyanins (AC) have the ability to inhibit cell proliferation, inflammation and angiogenesis and to stimulate apoptosis, cell differentiation and cell adhesion (15) . They do this by protectively modulating the expression levels of multiple genes and proteins in signaling pathways associated with various cellular functions including P13K/Akt/mTOR, AP-1, MAPK, Erk1/2, and p38 (cell proliferation), COX-2, iNOS, NF-ĸB, CD45, IL-1β, IL-12, IL-10 (inflammation), Muc-2, and various keratin genes (differentiation), VEGF, HIF-1α and CD34 (angiogenesis) and Bcl-2, Bax and caspase 3/7 (apoptosis) (15, (19) (20) (21) (22) (23) (24) (25) (26) . BRB also re-activate suppressor genes that have been silenced in tumors by hypermethylation (27, 28) .
The absorption and bioavailability of BRB constituents including the AC is a fundamental aspect of their physiological role in disease prevention. Recent studies have demonstrated that the uptake of orally administered BRB AC into blood is less than 1% of the administered dose (29, 30 they are metabolized by colonic bacteria into smaller, and more bioavailable phenolic acids such as protocatechuic acid (PCA) (31, 32) . PCA is known to function as an antioxidant and an anti-diabetic agent (33) . In addition, it is effective as a chemopreventive against colon, bladder and liver cancer in rodents (34) (35) (36) and has anti-proliferative and pro-apoptotic capabilities (37, 38) .
Our laboratory has used the Fischer-344 (F-344) rat model for studies of the etiology, biology and chemoprevention of esophageal SCC for several decades.
Esophageal tumors (mainly papillomas) are induced by subcutaneous (s.c.) injection of rats with the carcinogen, NMBA (9). Repeated s.c. injections of NMBA into rats dependably and reproducibly induce esophageal tumor formation within 15-to-26 weeks (wks). Preneoplastic changes closely resemble changes observed in human esophageal SCC including hyperplasia and mild, moderate and severe dysplasia. In the present study, we evaluated the relative ability of whole BRB, their component AC and PCA to prevent the development of esophageal cancer in F-344 rats. The actions of these agents were quantified in terms of their effects on the prevalence of preneoplastic lesions, tumor multiplicity and burden, and on the expression of the inflammatory markers COX-2, iNOS, NF-κB and soluble epoxide hydrolase (sEH). The effects on sEH expression was examined because this enzyme converts the anti-inflammatory epoxyeicosatrienoic acids (EET) into vincinal diols which are rapidly excreted (39) . sEH, therefore, is pro-inflammatory and there is interest in developing inhibitory agents for this enzyme. The effects of BRB, AC and PCA on the expression of pentraxin-3 (PTX3), a cytokine and anti-angiogenic factor (40) , was also examined because of the reported silencing of this gene in human esophageal SCC (41 
MATERIALS AND METHODS

Black raspberry powder
Freeze-dried black raspberry (Rubus occidentalis) powder was purchased from Decker Farms, Inc. (Hillsboro, OR) and from BerriProducts, Inc. (Corvallis, OR) and stored at 4°C in vacuum-sealed plastic bags at the Medical College of Wisconsin (MCW). About 100 g of each lot of powder from both vendors was shipped to Covance Laboratories (Madison, WI) for quantification of specific minerals, phenolic acids, vitamins, phytosterols, carotenoids, fungicides, pesticides, and herbicides as described before (14) . The content of the three major AC in each lot of BRB powder; i.e., cyanidin-3-Oglucoside, cyanidin-3-O-rutinoside and cyanidin-3-O-xylosylrutinoside, was determined in the laboratory of Dr. Stephen Hecht via high-performance liquid chromatography (HPLC). A portion of the powder was shipped from MCW to Dr. Hecht's laboratory to prepare the AC-enriched fraction, and the remaining powder was used in the carcinogenesis bioassay conducted at MCW. 
Preparation of the AC-enriched fraction
Extraction of freeze-dried BRB powder
Solvent removal
Most of the ethanol was first removed using a Bϋchi R-220 preparatory scale rotary evaporator set to a temperature of 22°C, a vacuum of approximately 15 torr and a speed of approximately 70 rpm. This stage was considered complete when there was a marked decrease in the rate of evaporation. In the second stage, the water-rich solutions were combined and rotary evaporated at the minimum temperature necessary to yield a drip-rate of 2-3 droplets/second without heating above 40°C. Rotary evaporation was stopped when the extract had reached the consistency of syrup, ~60%
solid by weight. The extract was then transferred to plastic jugs and stored at -20°C before overnight shipment under dry-ice to the MCW. Aliquots were removed for AC determination by HPLC and H2O content determination by lyophilization.
Analysis of AC in BRB extract
Total AC were determined by HPLC, as cyanidin-3-O-glucoside equivalents. Extract and standard solutions of cyanidin-3-O-glucoside (Extrasynthese, Genay Cedex, France) were prepared in 5% aqueous formic acid. The standard solution was further diluted with 0.1N HCl, the absorbance was measured at 510 nm using a Beckman DU-7400 spectrophotometer for standardization.
HPLC was performed using a Luna C18 (2) switched to 100% B in 0.5 mins and held for 5 mins, before returning to 100% A in 0.5 mins and re-equilibrating for 10 mins. The flow rate was 0.9 mL/mins.
Chemicals
NMBA was purchased from Ash Stevens (Detroit, MI) and was found to be >98% pure by HPLC. Protocatechuic acid ethyl ester (PCA, 97% pure) was purchased from Sigma-Aldrich (St. Louis, MO).
Diet Preparation
Diets were prepared using a Hobart mixer. BRB powder, the AC enriched fraction, or 
Chemoprevention bioassay
Rats were randomly assigned to five separate groups and placed on AIN-76A diet for one week (wk) to acclimatize to the facility. They were then given s.c. injections with 0. 
Histological analysis
Formalin-fixed esophageal tissue was paraffin embedded, cut, stained by H&E, and evaluated by routine histopathology. Areas of normal tissue, hyperplasia, low-and high-grade dysplasia were scored and quantified based on their occurrence within each esophagus as described by Kresty, et al. 2001 (14) . RNA from each esophagus was extracted using a DNA/RNA kit (Qiagen, Valencia, CA).
RNA was then standardized and converted to cDNA using Superscript III reverse transcriptase (Life Technologies, Brown Deer, WI). COX-2, iNOS, NF-κB, sEH mRNA expression was quantified using exon specific primers in a SYBR green based qPCR assay, using GAPDH as an internal control (Life Technologies). These levels were statistically analyzed using the (2 
Measurement of PTX3 in plasma
Whole blood was collected in heparin coated tubes (BD Biosciences, San Jose, CA), centrifuged at 3,000x g for 10 mins, and plasma collected and stored at −80°C until analyzed. 100 μL of plasma from each rat was used to quantify PTX3 concentrations using an enzyme-linked immunosorbent assay (ELISA) (Cusabio, Carlsbad, CA).
Pyrosequencing
DNA was extracted from snap frozen esophageal epithelium (Qiagen) and standardized to 500 ng. It was then bisulfite converted using an EZ DNA Methylation Kit (Zymo Research, Orange, CA). A region within the PTX3 gene in each esophagus was amplified via PCR and the product was sequenced using a pyrosequencer (Qiagen).
Gene methylation of PTX3 was quantified using PyroQ-CpG software (Qiagen).
Immunoblotting
Cancer Research. 
Statistical Analysis
Body weight, food consumption, tumor multiplicity and burden, histopathological analysis and immunohistochemical staining data, qPCR analysis, plasma PTX3 levels, and western blot image density analysis were compared using ANOVA via Prism 5
(GraphPad). A P value < 0.05 was considered to be statistically significant. The posthoc test used was Tukey's test in which all treatment groups were compared to the AIN-76A diet + NMBA-injection group.
RESULTS
General observations
There were no significant differences in animal body weights or food consumption throughout the course of the study (P> 0.05; data not shown). Esophageal tumors were examined under a light microscope and all were found to have the histological features of squamous cell papillomas. No tumors were seen in any DMSO-injected animals at any time point, and no invasive carcinomas were identified in the stroma or muscle tissue of any NMBA-treated esophagi at any time point. This was not unexpected because NMBA-treated rats are typically euthanized before carcinomas develop due to occlusion of the lumen of the esophagus by the expanding papillomas. BRB, AC, and PCA diets were well tolerated and did not produce any gross or histological abnormalities in the esophagus, liver, intestinal tract, kidneys or spleen of any of the treated rats.
Effects of diets on NMBA-induced preneoplastic lesions and tumors
Effects on NMBA-induced preneoplastic lesions
The inhibition of preneoplastic esophageal lesions by the administered diets is summarized in Table 2 . At wk 15, when compared to NMBA control rats, the esophagi of rats fed diets supplemented with BRB, AC, or PCA had reduced areas of hyperplasia 
Inflammatory marker expression in NMBA-treated rats
Previous studies have shown that BRB and their component AC reduce the mRNA and protein expression levels of the inflammatory markers, COX-2, iNOS, and NF-κB in NMBA-treated rat esophagus (15, 21) . Based on these observations, we determined if PCA might exhibit similar down-regulatory effects on these markers. In addition, the effects of all three experimental diets on the expression of the pro-inflammatory enzyme, sEH, was determined.
mRNA expression
Relative mRNA expression levels of the above-mentioned inflammatory markers in the esophagi of all animals in the study are summarized in Figs. 2A-D . At wks 15 and 35 all treatment groups decreased the expression levels of sEH mRNA compared to the NMBA control rats (P< 0.05) ( Fig. 2A) , while no significant change was observed at wk 25 (P> 0.05). COX-2 ( Fig. 2B) and iNOS ( Fig. 2C) were not affected by any of the diets at wks 15 and 25 (P> 0.05). At wk 35, all three diets reduced COX-2 ( Fig. 2B ) mRNA expression levels (P<0.05), while the BRB and PCA diets, but not the AC diet, decreased the total iNOS mRNA levels (P< 0.05) (Fig. 2C) . No change in the expression of NF-κB mRNA was found with any of the dietary treatments at any time point (P> 0.05) (Fig. 2D) . These results suggest that BRB, AC and PCA are more likely to influence the expression levels of the inflammatory markers at a later stage of esophageal carcinogenesis, and that these agents vary in their ability to influence the expression levels of specific inflammatory markers.
Western blot
Protein levels of the inflammatory markers were determined by Western blot only at wk 35 (Figs. 3A-C) because the esophageal tissues at wks 15 and 25 were insufficient for analysis. For each marker, esophagi from 3 rats per diet group were analyzed and the band image densities quantified and compared to the β-actin band density. COX-2 protein expression was significantly reduced by the BRB and AC diets but not the PCA diet (P< 0.05) (Fig. 3B) . Expression of sEH protein (Fig. 3B) (Fig. 3B) , but not by the AC diet (P> 0.05). These data correlated positively with mRNA expression results. Naïve NF-κB expression was not altered by any of the diets (P> 0.05) (Fig. 3C) ; however, p-NF-κB expression was reduced by all three diets (P< 0.05) (Fig. 3C) . Collectively, these data suggest that BRB, AC, and PCA all reduce inflammation in the esophagus and, potentially, by differential effects on individual biomarkers.
PTX3 expression
We presumed that PTX3 could be a new anti-inflammatory marker for esophageal tumors in rats because its expression was shown to be highly down-regulated in human ESCC cell lines and tissue through hypermethylation of the promoter region (41) . In addition, PTX3 has been shown to elicit anti-carcinogenic effects via its ability to prevent neutrophil migration into tissue sites during acute lung injury (43) , as well as antiangiogenic effects (40, 44) .
Plasma PTX3 levels
No differences in plasma PTX3 levels were observed in any diet group at wk 15 (P> 0.05) (Fig. 4A) . At wk 25, the plasma PTX3 level in PCA-fed rats was significantly higher than in rats treated with NMBA only (P< 0.05) (Fig. 4A) . At wk 35, BRB-, AC-and PCAfed rats all had higher plasma PTX3 levels when compared to NMBA-treated rats on control diet (P< 0.05) (Fig. 4A) .
Western blot analysis
A representative blot depicts the relative levels of PTX3 expression of the five experimental groups (Fig. 4B) by all three experimental diets to levels similar to the vehicle control based on image density analysis (P< 0.05) (Fig. 4C) .
PTX3 methylation
Extracted esophageal DNA was analyzed for the relative percentage of DNA methylation at wks 15, 25, and 35 (Fig. 4D) . No significant differences were seen in relative DNA methylation across all diet groups and time points (P> 0.05). These results suggest that the mechanism for downregulation of PTX3 expression in NMBA-induced rat esophageal papillomas is not through hypermethylation of the PTX3 gene as is the case in human esophageal SCC (41) .
DISCUSSION
We reported that synthetic AIN-76A diet containing either 5% or 10% BRB was effective at reducing NMBA-induced esophageal carcinogenesis in rats (14) . Continued research demonstrated that the four AC in BRB are nearly as effective as whole BRB in reducing esophageal carcinogenesis (15) . Results from the present study confirm the chemopreventive activity of whole BRB and BRB AC against NMBA-induced rat esophageal carcinogenesis and also demonstrate the ability of PCA, a major metabolite of BRB AC, to reduce esophageal carcinogenesis. A pharmacokinetic study in humans indicated that about 70% of the administered AC in BRB are converted to PCA in the human gut (45, 46) . Therefore, for comparative purposes, we fed rats an amount of PCA (500 ppm in the diet) equivalent to about 70% of the anthocyanin content in the AC-enriched diet. The observation that PCA was effective at this dose suggests that it may be responsible for at least some of the chemopreventive activity of whole BRB and 
BRB AC. Further studies are underway to confirm this observation including a metabolism study to determine the extent of PCA production from BRB AC by microbiota in the rat intestine. If confirmed, then PCA would appear to be worthy of additional evaluation as a chemopreventive agent for the esophagus and potentially other organs. When compared to whole BRB and the AC fraction, PCA has several advantages for chemoprevention in that it delivers a constant dose, is commercially available at low cost, and it is more readily bioavailable than the cyanidin-type AC found in BRB (47) .
Consistent with their ability to inhibit NMBA-induced tumors in the rat esophagus, the BRB, AC and PCA diets were all effective at reducing premalignant lesions. When compared to the NMBA control group, all three diets appeared to cause a delay in the formation of preneoplastic lesions in NMBA-treated esophagus as well as the progression of these lesions to papillomas. The delay in formation of preneoplastic lesions was observed as early as 15 wks after the first injection of NMBA (postinitiation). The BRB and AC results confirm earlier data (15, 20) , and lend credence to the concept of using these agents in human clinical trials involving patients with endoscopically-identified preneoplastic esophageal lesions as was done with strawberry powder in Chinese patients by Chen et al. (16) . With additional experimentation, PCA may also prove to be a viable candidate for these trials.
The present study also confirms earlier data demonstrating the inhibitory effects of whole BRB and their component AC on inflammatory biomarkers and extends these activities to PCA. The AC repeatedly decreased expression of the inflammatory markers; COX-2, activated NF-ĸB, PTX3 and sEH at levels similar to whole BRB 
powder. PCA appeared to be active in reducing inflammatory biomarkers but less so than the BRB. The relative efficacy of these three agents to reduce esophageal tumorigenesis and preneoplastic lesions, therefore, appears to parallel their relative inhibitory effects on the inflammatory markers. The enhanced ability of BRB to reduce the inflammatory markers may be due to an additive effect of other compounds in BRB such as ellagic, ferulic and chlorogenic acids and quercetin, or to their fiber content. For example, the fiber fraction of fruits has been shown to select for, and enhance the production of, specific bacterial types in the intestine that exhibit anti-inflammatory effects (48) . In that regard, we have shown that the residue (non-alcohol soluble) or fiber fraction of BRB has chemopreventive activity for NMBA-treated rat esophagus (15) .
Recent work has also indicated that the PTX3 promoter is hypermethylated in human ESCC cell lines and esophageal tumor tissue (41). This was not observed in NMBA-treated rat esophagus in the present study. PTX3 has both anti-angiogenic and anti-tumorigenic activity in human prostate cancer cell lines (40) , and steroid-hormone regulated tumors S115 (mouse mammary tumor cells) (49) . Interestingly, PCA was the most effective treatment at inducing PTX3 expression in the plasma at the 25 wk time point (PTX3 plasma level = 0.47 pg/ml compared to 0.23 pg/ml in the NMBA-control), but this was reduced to the same level as in BRB-and AC-treated rats at 35 wks. The increased level at 25 wks may account for the decrease in high grade dysplasia seen at 25 wks in the PCA treated group. As PTX3 has been shown to alter immune cell migration via inhibiting P-selectin mediated rolling adhesion (43) , this altered cytokine expression may lead to changes in esophagus immune cell trafficking. shows that naive NF-κB expression was unchanged, while p-NF-κB expression was significantly reduced by the BRB, AC, and PCA diets. Columns, mean (n=3), bars, SD.
*, significantly lower (P< 0.05) than rats treated with NMBA and fed control diet. 
